Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

INOC - Istituto Nazionale Oncologico Candiolo

Other

inoc.it/en/Candiolo, Turin, Italy, Italy
6 profile visits

About

INOC is a major Italian comprehensive cancer center (OECI CCC since 2022) internationally recognized for excellence in integrated cancer research, care, prevention, and early detection. Since 2013, INOC has been accredited by the Ministry of Health (Italy) as an “Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)”.

INOC aims to strengthen cooperation and collaboration with other EU CCCs and networks for new projects development in the oncological context. INOC is an active member of EUnetCCC (WP4-6-7-8-9) and it has been involved in, among others, CCI4EU, ProCancer-AI, GenomeMET1-2, INTERACT-EU, NGS as well as various ERC/EIC/TRASCAN/EpPerMed. It is also actively engaging the private sector for supporting research and collaborative projects.

INOC hosts a fully integrated translational research platform – BioLife - designed to interface patient-derived biospecimens and data with advanced preclinical modelling and downstream molecular profiling. It includes 18 Laboratories and Clinical Services.

INOC's Clinical Research Unit (CRU) currently coordinates 90 international and multicentre trials in partnership with all the main industry sponsors. INOC has a Phase-1 Trial Unit. INOC has been the first centre activated in Italy 5 times and in Europe 2 times, achieved first-in-patient- nationally on 3 occasions and globally once, and ranked as top European enrolled 2 times, demonstrating rapid activation, strong candidate identification, and sustained delivery across studies

Representatives

EU project manager

INOC - Istituto Nazionale Oncologico Candiolo